Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April 29, 2023, Mrs. Birute Norkute resigned from her position as Chief
Operating Officer ("COO") of Progressive Care Inc. (the "Company"), effective
May 1, 2023. Mrs. Norkute will remain engaged with the Company as Operations
Manager ("OM"). There has been no modifications of Mrs. Norkute's compensation
or benefits in connection with the change of Mrs. Norkute's position from COO to
OM.
Effective May 1, 2023, Dr. Pamela Roberts serves as Chief Operating Officer of
the Company. Prior to her appointment as COO, Dr. Roberts served as the
Company's Director of Pharmacy and Pharmacist in Charge. In connection with such
appointment, Dr. Roberts has entered into an employment agreement ("Employment
Agreement"), which increased her base salary to $180,000 in addition to certain
other benefits. The foregoing description of the Employment Agreement does not
purport to be complete and is qualified in its entirety by the text of the
Employment Agreement, which is filed as Exhibit 10.1 to this Current Report on
Form 8-K.
Pamela M. Roberts, PharmD, Chief Operating Officer, age 48
Dr. Roberts was appointed as Chief Operating Officer in May 2023. Dr. Roberts is
a medical professional and has almost 20 years of experience as a licensed
pharmacist. Dr. Roberts has been the Director of Pharmacy for PharmcoRX
Pharmacies for the last 5 years. Dr. Roberts is also Pharmacist In Charge for
PharmcoRX location 901 for the last 11 years. She is the recipient of the 2020
PHMA Frontline Worker of the Year Award. Dr. Roberts is a licensed Pharmacist in
the State of Florida and Texas. She received her Doctor of Pharmacy Degree from
Hampton University in Hampton, Virginia.
Dr. Roberts was not appointed as COO pursuant to any arrangements or
understandings with the Company or with any other person, there are no family
relationships between Dr. Roberts and any director or executive officer of the
Company required to be disclosed under Item 401(d) of Regulation S-K, and Dr.
Roberts has no direct or indirect interest in any transaction or proposed
transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
Item 9.01 Exhibits.
Exhibit No. Documents
10.1 Form of Employment Agreement by and between the Company and Pamela
Roberts, dated May 1, 2023
104 Cover Page Interactive Data File (formatted as Inline XBRL)
© Edgar Online, source Glimpses